Ascend Wellness Holdings (AAWH) Cash from Investing Activities (2020 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Cash from Investing Activities came in at -$4.8 million in Q1 2026, up 39.43% year-on-year from -$3.4 million in Q1 2025, and up 71.65% quarter-over-quarter from -$16.8 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$4.8 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 39.43% year-over-year to -$4.8 million in Q1 2026; TTM through Mar 2026 was -$42.6 million, a 0.96% increase from a year earlier, with the FY2025 full-year figure at -$45.7 million, down 22.96% from the prior year.
  • Cash from Investing Activities climbed to -$4.8 million in Q1 2026 per AAWH's latest filing, from -$16.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$622000.0 in Q1 2022 and bottomed at -$47.7 million in Q2 2022.
  • The 5-year median for Cash from Investing Activities is -$11.1 million (2024), against an average of -$15.4 million.
  • Across the five-year window, Cash from Investing Activities surged 98.23% in 2022 and sank 813.02% in 2023, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$19.7 million in 2022, then soared by 58.62% to -$8.2 million in 2023, then rose by 11.8% to -$7.2 million in 2024, then plunged by 133.08% to -$16.8 million in 2025, then soared by 71.65% to -$4.8 million in 2026.
  • Per Business Quant, the three latest AAWH Cash from Investing Activities figures stand at -$4.8 million (Q1 2026), -$16.8 million (Q4 2025), and -$12.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -60.00 Mn
10 Ascend Wellness Holdings 78.95 Mn 18.03 Mn 44.88 Mn -4.75 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.75 Mn
Mar 31, 2026 -4.75 Mn
Dec 31, 2025 -16.76 Mn
Dec 31, 2025 -16.76 Mn
Sep 30, 2025 -12.54 Mn
Sep 30, 2025 -12.54 Mn
Jun 30, 2025 -8.59 Mn
Jun 30, 2025 -8.59 Mn
Mar 31, 2025 -7.85 Mn
Mar 31, 2025 -7.85 Mn
Dec 31, 2024 -7.19 Mn
Dec 31, 2024 -7.19 Mn
Sep 30, 2024 -11.14 Mn
Sep 30, 2024 -11.14 Mn
Jun 30, 2024 -16.88 Mn
Jun 30, 2024 -16.88 Mn
Mar 31, 2024 -1.99 Mn
Mar 31, 2024 -1.99 Mn
Dec 31, 2023 -8.15 Mn
Dec 31, 2023 -8.15 Mn